Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kusner

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
American Journal of Physiology. Cell Physiology|October 16, 2001
Phenotypic analysis of conditionally immortalized cells isolated from the BPK model of ARPKDW E Sweeney, L Kusner, C R Carlin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1976
3-(Hydroxymethyl)-8-methoxychromone and unconjugated metabolites in rat plasma. Identification of the biologically active speciesF J De Carlo, D J Herzig, E J Kusner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: inhibition of SK1 translocation by Mycobacterium tuberculosisChristopher R Thompson, Shankar S Iyer, Natalie Melrose, et al.
Cancer Research|March 15, 2015
Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating CellsNicholas Borcherding, David Kusner, Ryan Kolb, et al.
Scientific Reports|April 15, 2025
Serum fibrinogen is not elevated in patients with myasthenia gravisTaylor A Bauman, Sean M Lee, Vern C Juel, et al.
Gene|May 19, 1995
CciNI, an isoschizomer of NotI from Curtobacterium citreum recognizes 5'-GC decreases GGCCGC-3'V S Dedkov, N I Rechkunova, E A Prihod'ko, et al.
American Heart Journal|May 22, 2024
Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosisJonathan Kusner, Ravi B Patel, Mo Hu, et al.
Scientific Reports|September 26, 2025
Refinement of the rat acetylcholine receptor-specific passive transfer myasthenia gravis model using subcutaneous injections: an update to the guidelinesBritt Arets, Marina Mané-Damas, Anja K Schöttler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2014
Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravisYan Li, Zhidan Tu, Shiguang Qian, et al.
Journal of Medicinal Chemistry|April 29, 1994
Synthesis, structure-activity relationships, and pharmacological evaluation of a series of fluorinated 3-benzyl-5-indolecarboxamides: identification of 4-[[5-[((2R)-2-methyl-4,4,4-trifluorobutyl)carbamoyl]-1-methyl indol- 3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]benzamide, a potent, orally active antagonist of leukotrienes D4 and E4R T Jacobs, P R Bernstein, L A Cronk, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
American Journal of Physiology. Cell Physiology|October 16, 2001
Phenotypic analysis of conditionally immortalized cells isolated from the BPK model of ARPKDW E Sweeney, L Kusner, C R Carlin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1976
3-(Hydroxymethyl)-8-methoxychromone and unconjugated metabolites in rat plasma. Identification of the biologically active speciesF J De Carlo, D J Herzig, E J Kusner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: inhibition of SK1 translocation by Mycobacterium tuberculosisChristopher R Thompson, Shankar S Iyer, Natalie Melrose, et al.
Cancer Research|March 15, 2015
Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating CellsNicholas Borcherding, David Kusner, Ryan Kolb, et al.
Scientific Reports|April 15, 2025
Serum fibrinogen is not elevated in patients with myasthenia gravisTaylor A Bauman, Sean M Lee, Vern C Juel, et al.
Gene|May 19, 1995
CciNI, an isoschizomer of NotI from Curtobacterium citreum recognizes 5'-GC decreases GGCCGC-3'V S Dedkov, N I Rechkunova, E A Prihod'ko, et al.
American Heart Journal|May 22, 2024
Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosisJonathan Kusner, Ravi B Patel, Mo Hu, et al.
Scientific Reports|September 26, 2025
Refinement of the rat acetylcholine receptor-specific passive transfer myasthenia gravis model using subcutaneous injections: an update to the guidelinesBritt Arets, Marina Mané-Damas, Anja K Schöttler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2014
Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravisYan Li, Zhidan Tu, Shiguang Qian, et al.
Journal of Medicinal Chemistry|April 29, 1994
Synthesis, structure-activity relationships, and pharmacological evaluation of a series of fluorinated 3-benzyl-5-indolecarboxamides: identification of 4-[[5-[((2R)-2-methyl-4,4,4-trifluorobutyl)carbamoyl]-1-methyl indol- 3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]benzamide, a potent, orally active antagonist of leukotrienes D4 and E4R T Jacobs, P R Bernstein, L A Cronk, et al.
Pageof 16